首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   32245篇
  免费   2867篇
  国内免费   1324篇
耳鼻咽喉   393篇
儿科学   627篇
妇产科学   584篇
基础医学   3923篇
口腔科学   556篇
临床医学   3413篇
内科学   5449篇
皮肤病学   965篇
神经病学   2136篇
特种医学   1125篇
外国民族医学   13篇
外科学   4115篇
综合类   3961篇
现状与发展   4篇
一般理论   19篇
预防医学   1954篇
眼科学   1132篇
药学   2569篇
  17篇
中国医学   1083篇
肿瘤学   2398篇
  2023年   392篇
  2022年   462篇
  2021年   1205篇
  2020年   1028篇
  2019年   965篇
  2018年   1092篇
  2017年   965篇
  2016年   985篇
  2015年   1279篇
  2014年   1578篇
  2013年   1551篇
  2012年   2310篇
  2011年   2358篇
  2010年   1368篇
  2009年   1173篇
  2008年   1671篇
  2007年   1695篇
  2006年   1672篇
  2005年   1662篇
  2004年   1210篇
  2003年   1034篇
  2002年   927篇
  2001年   781篇
  2000年   809篇
  1999年   794篇
  1998年   485篇
  1997年   403篇
  1996年   321篇
  1995年   341篇
  1994年   288篇
  1993年   205篇
  1992年   358篇
  1991年   302篇
  1990年   316篇
  1989年   293篇
  1988年   270篇
  1987年   235篇
  1986年   225篇
  1985年   161篇
  1984年   140篇
  1983年   88篇
  1982年   65篇
  1981年   72篇
  1980年   58篇
  1979年   74篇
  1978年   62篇
  1977年   59篇
  1974年   67篇
  1973年   69篇
  1972年   69篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.

Background  

Tumor recurrence after resection of hepatocellular carcinoma is a common phenomenon. Re-resection and radiofrequency ablation (RFA) are good options for treating recurrent HCC. This study compared the efficacy of these two modalities in the treatment of intrahepatic HCC recurrence after hepatectomy.  相似文献   
992.
993.
In this report, we describe the technique of muscle and nerve sparing latissimus dorsi (LD) flap and evaluate the outcomes of reconstruction of various defects with 12 free and 2 pedicled muscle and nerve sparing LD flaps in 14 patients. The LD muscle functions at operated and nonoperated muscles were evaluated clinically and with electroneuromyography. All flaps survived completely but one which had a partial necrosis. The mean follow-up time was 12.3 months. Adduction and extention ranges of the shoulders were the same bilaterally in all patients. In electroneuromyography, no significant difference was available statistically between the sides. This muscle and nerve sparing latissimus dorsi flap has advantages of thinness, muscle preservation and reliability, and thus can be a good option to other fasciocutaneous flaps in reconstruction surgery.  相似文献   
994.
Riva FM  Chen YC  Tan NC  Lin PY  Tsai YT  Chang HW  Kuo YR 《Microsurgery》2012,32(5):339-343
Free tissue transfer has become a popular technique for soft tissue defect reconstruction in head and neck cancer ablation. Although high success rates and good reliability of free flaps are proven, microvascular thrombosis is still the most critical issue for microsurgeons. Pharmacological antithrombotic agents are widely used but their efficacy is still debated. In this study, we analyzed whether prostaglandin-E1 (PGE1) and dextran-40 can improve the outcomes compared to no antithrombotic therapy at all. We retrospectively reviewed 1,351 free flaps performed for head and neck reconstruction after cancer ablation. Three groups defined were 232 flaps received PGE1, 283 flaps received dextran-40, and 836 received no antithrombotic therapy. The demographics of these three groups indicated no statistical differences. The results showed that flap survival revealed no significant difference among PGE1, dextran-40, and control group (P = 0.734). There was a tendency to hematomas in PGE1 group (P = 0.056) when compared with other two groups. Dextran-40 significantly increased flap failure rate in high-risk patients with diabetes mellitus (P = 0.006) or hypertension (P = 0.003), when compared with PGE1 and control group. These results revealed antithrombotic therapy with PGE1 and dextran-40 do not determine a significant improvement in flap survival.  相似文献   
995.
目的:双盲比较研究血清学方法、单克隆抗体(单抗)方法和DNA方法用于中国汉族人群HLA-A抗原分型的精确性。方法:研究样本296份,包括143名无关供者和153例等待肾移植受者。血清学方法为二步法微量淋巴细胞毒分型技术;单抗法为一步法单抗分型技术;DNA方法采用顺序特异引物聚合酶反应(PCR-SSP)技术。结果:所有样本DNA分型匀获得成功,重复率100%,分型结果经标准DNA验证和美国加州大学配  相似文献   
996.
BackgroundThe clinical syndrome of frailty identified through the assessment of weight loss, gait speed, grip strength, physical activity, and physical exhaustion has been used to identify patients with reduced reserves. We hypothesized that frailty is useful in predicting adverse outcomes in optimized elective elderly colorectal surgery patients.MethodsA prospective study was conducted at 2 centers (Singapore and Japan). All patients over 75 years of age undergoing colorectal resection were assessed for the presence of the syndrome of frailty. All these patients had already had their comorbidities optimized for surgery. The outcome measure was postoperative major complications (defined as Clavien-Dindo type II and above complications).ResultsEighty-three patients were studied from February 2008 to April 2010. The mean age was 81.5 years (range 75–93 years). The mean comorbidity index was 3.37 (range 0–11). Twenty-six (31.3%) patients were an American Society of Anesthesiologists (ASA) score of 3 and above. Chi-square analysis revealed that the odds ratio of postoperative major complications was 4.083 (95% confidence interval, 1.433–11.638) when the patient satisfied the criteria for frailty. Albumin <35, ASA >3, comorbidity index >5, and Physiologic and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM) scores were not predictive of postoperative major complications.ConclusionsPreliminary findings show that frailty is a potent adjunctive tool of predicting postoperative morbidity. Frailty can be used to identify elderly patients needing further optimization before major surgery.  相似文献   
997.
A. T. H. Sia  H. S. Tan  B. L. Sng 《Anaesthesia》2012,67(12):1348-1355
Hypotension occurs in most caesarean sections under spinal anaesthesia, necessitating vasopressor administration. However, the optimal dosing regimen remains unclear. We have developed a novel vasopressor delivery system that automatically administers phenylephrine or ephedrine based on continuous non‐invasive blood pressure monitoring. This prospective cohort study recruited 55 healthy women under standardised spinal anaesthesia with 2.2 ml hyperbaric bupivacaine 0.5%, 15 μg fentanyl and 100 μg morphine. A 50‐μg phenylephrine bolus was given at 1‐min intervals when systolic blood pressure fell below 90% of baseline, and a 4‐mg ephedrine bolus was given when hypotension developed with bradycardia (heart rate <60 beats.min?1). Systolic blood pressure was within 20% of baseline in 88% of all measurements. Six patients (11%) had one or more measurements above 120% of baseline (1% of all measurements), whereas 36 (65%) had at least one reading below 80% of baseline (11% of total measurements). The system maintained systolic blood pressure at a mean (SD) of ?9.1 (7.0)% below baseline, with 5.4 (2.5)% fluctuation. Two patients (4%) experienced pre‐delivery nausea. All 5‐min Apgar scores were 9.  相似文献   
998.
We examined the pre‐emptive analgesic effect of a cyclooxygenase (COX)‐2 inhibitor in a rat surgical pain model and characterised the changes in cutaneous COX‐2 around a surgical site. Thermal hyperalgesia and mechanical allodynia were tested in the rats for three days after incision and skin tissues were collected for analysis of COX‐2. There was decreased expression of cutaneous COX‐2 one day after surgical incision. Pre‐incision injection of the COX‐2 inhibitor significantly inhibited expression of COX‐2 and also reduced thermal hyperalgesia (but not mechanical allodynia) compared with the post‐incision COX‐2‐inhibitor injection group, one day after incision.  相似文献   
999.
目的探讨区域性大型活动卫生保障二次供水风险评价指标,建立风险评价模型,为区域性大型活动接待单位的事先遴选和开展二次供水卫生保障工作提供科学依据。方法采用Delphi专家咨询法方法研究确定二次供水风险评价指标体系及其权重;采用综合指数法建立线形风险评价模型。结果 30名咨询专家的平均专业工作经历为20.63±5.80年,两轮的应答率均为100%,权威系数分别为0.86±0.06、0.89±0.06,Kendall协调系数分别为0.761(X2=292.348,P<0.01),0.906(X2=363.588,P<0.01),经卡方检验均具有统计学意义;确定了区域性大型活动卫生保障二次供水风险评价的一级指标3项、二级指标10项,以及各项指标的权重,其中一级指标卫生管理、设施管理、水质管理的平均权重分别为2.02、3.94和4.04;建立了线形风险评价模型。结论区域性大型活动卫生保障二次供水线形风险评价模型的建立可为二次供水卫生保障工作提供科学依据,具有推广应用价值。  相似文献   
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号